Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Pathol ; 230(4): 388-98, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23649916

ABSTRACT

CD146 is an adhesion molecule localized at endothelial cell junctions and facilitates cell-cell interactions. The circulating soluble form (sCD146) lacks both the intracellular and the transmembrane domains. In this study we show that CD146 expression was significantly decreased in the lung tissue of smokers with chronic obstructive pulmonary disease (COPD) and also in rats exposed to second-hand smoke (SHS). Concurrently, levels of sCD146 were increased in both the plasma and bronchoalveolar lavage fluid (BALF) of COPD patients as well as in BALF from rats exposed to SHS. Decreased or abolished CD146 protein expression in rat pulmonary micro- and macrovascular endothelial cells was found after treatment with cigarette smoke extract (CSE), proinflammatory cytokine interleukin 18 (IL-18) or after silencing CD146 expression with siRNA. The decrease in CD146 protein was accompanied by increased endothelial monolayer permeability and enhanced macrophage infiltration in vitro. In CD146 knockout (KO) mice, distinct perivascular oedema was seen and increased numbers of inflammatory cells, along with increased protein levels in BALF. Increased sCD146 was found in BALF and plasma from patients with COPD. The circulating plasma levels of sCD146 correlated positively with the presence of anti-endothelial cell antibodies (AECAs). sCD146 in combination with AECAs may be useful markers for early detection of COPD. Our study indicates that loss of CD146 function damages pulmonary endothelial integrity. This damage may represent part of the pathophysiological processes that are involved in the basic aetiology of COPD/emphysema.


Subject(s)
CD146 Antigen/metabolism , Endothelial Cells/immunology , Lung/blood supply , Pulmonary Disease, Chronic Obstructive/immunology , Pulmonary Emphysema/immunology , Aged , Animals , Autoantibodies/blood , Biomarkers/blood , Bronchoalveolar Lavage Fluid/immunology , CD146 Antigen/analysis , CD146 Antigen/blood , CD146 Antigen/genetics , Capillary Permeability , Case-Control Studies , Cells, Cultured , Disease Models, Animal , Early Diagnosis , Endothelial Cells/metabolism , Endothelial Cells/pathology , Female , Gene Expression Regulation , Humans , Interleukin-18/metabolism , Lung/immunology , Lung/pathology , Macrophages/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , Predictive Value of Tests , Pulmonary Disease, Chronic Obstructive/blood , Pulmonary Disease, Chronic Obstructive/genetics , Pulmonary Disease, Chronic Obstructive/pathology , Pulmonary Edema/immunology , Pulmonary Edema/pathology , Pulmonary Emphysema/blood , Pulmonary Emphysema/genetics , Pulmonary Emphysema/pathology , RNA Interference , Rats , Rats, Sprague-Dawley , Tobacco Smoke Pollution , Transfection
2.
Parasitol Int ; 63(1): 171-86, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24076429

ABSTRACT

Plasmodium falciparum malaria is responsible for the deaths of over half a million African children annually. Until a decade ago, dynamic analysis of the malaria parasite was limited to in vitro systems with the typical limitations associated with 2D monocultures or entirely artificial surfaces. Due to extremely low parasite densities, the liver was considered a black box in terms of Plasmodium sporozoite invasion, liver stage development, and merozoite release into the blood. Further, nothing was known about the behavior of blood stage parasites in organs such as the brain where clinical signs manifest and the ensuing immune response of the host that may ultimately result in a fatal outcome. The advent of fluorescent parasites, advances in imaging technology, and availability of an ever-increasing number of cellular and molecular probes have helped illuminate many steps along the pathogenetic cascade of this deadly tropical parasite.


Subject(s)
Brain/parasitology , Liver/parasitology , Lung/parasitology , Microscopy/methods , Plasmodium/cytology , Animals , Brain/immunology , Liver/immunology , Lung/immunology , Plasmodium/physiology
3.
Front Physiol ; 4: 91, 2013.
Article in English | MEDLINE | ID: mdl-23720629

ABSTRACT

Chronic Obstructive Pulmonary Disease (COPD) is one of the foremost causes of death worldwide. It is primarily caused by tobacco smoke, making it an easily preventable disease, but facilitated by genetic α-1 antitrypsin deficiency. In addition to active smokers, health problems also occur in people involuntarily exposed to second hand smoke (SHS). Currently, the relationship between SHS and COPD is not well established. Knowledge of pathogenic mechanisms is limited, thereby halting the advancement of new treatments for this socially and economically detrimental disease. Here, we attempt to summarize tobacco smoke studies undertaken in animal models, applying both mainstream (direct, nose only) and side stream (indirect, whole body) smoke exposures. This overview of 155 studies compares cellular and molecular mechanisms as well as proteolytic, inflammatory, and vasoreactive responses underlying COPD development. This is a difficult task, as listing of exposure parameters is limited for most experiments. We show that both mainstream and SHS studies largely present similar inflammatory cell populations dominated by macrophages as well as elevated chemokine/cytokine levels, such as TNF-α. Additionally, SHS, like mainstream smoke, has been shown to cause vascular remodeling and neutrophil elastase-mediated proteolytic matrix breakdown with failure to repair. Disease mechanisms and therapeutic interventions appear to coincide in both exposure scenarios. One of the more widely applied interventions, the anti-oxidant therapy, is successful for both mainstream and SHS. The comparison of direct with indirect smoke exposure studies in this review emphasizes that, even though there are many overlapping pathways, it is not conclusive that SHS is using exactly the same mechanisms as direct smoke in COPD pathogenesis, but should be considered a preventable health risk. Some characteristics and therapeutic alternatives uniquely exist in SHS-related COPD.

4.
Mol Biochem Parasitol ; 169(2): 101-7, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19896981

ABSTRACT

Histomonas meleagridis is a protozoan parasite known to cause histomonosis (syn. typhlohepatitis) in poultry. Due to the economic losses which the disease entails, there is an urgency to understanding its pathogenesis. In the present investigation, three partial cDNA sequences encoding heterogenic alpha-actinins previously identified for H. meleagridis were completed and characterized. These three H. meleagridis alpha-actinin isoforms were named alpha-actinin1, alpha-actinin2, and alpha-actinin3. Through mRNA analysis, it was possible to estimate their expected complete coding lengths to ca. 1.9kb, 3.5kb, and 3kb, respectively. Protein structure predictions of completed cDNA sequences revealed that the three H. meleagridis alpha-actinins contain two N-terminal calponin homology (CH) domains that bind actin, a central rod domain of varying lengths, and only one C-terminal EF-Hand. The well conserved N- and C-termini of the H. meleagridis alpha-actinins show amino acid identities between 54% and 82.5% to those of the related trichomonad Trichomonas vaginalis. Additionally, all three alpha-actinins were shown to immune-react with turkey antiserum, while only the immune reaction of alpha-actinin2 and alpha-actinin3 was visible using chicken serum. This demonstrates the antigenic potential of alpha-actinins in host animals. The identification of alpha-actinins with varying rod domain lengths within one organism is a relatively new concept, described as yet only for Entamoeba histolytica.


Subject(s)
Actinin/genetics , Actinin/immunology , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Trichomonadida/immunology , Amino Acid Sequence , Animals , Antibodies, Protozoan/blood , Chickens/immunology , Chickens/parasitology , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , DNA, Protozoan/genetics , DNA, Protozoan/isolation & purification , Molecular Sequence Data , Protein Structure, Tertiary , Sequence Alignment , Turkeys/immunology , Turkeys/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL